Studies related to Sleep Quality and Cannabis

Cannabinoids For Treatment Of Spasticity And Other Symptoms Related To Multiple Sclerosis (CAMS Study): Multicentre Randomised Placebo-controlled Trial

Effect Increase
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 630
Sex Both Genders
Age Range 45-64, 65+
Body Types Average
Notes for this study:
In persons with multiple sclerosis given either pure THC or cannabis extracts over 15 weeks, supplementation failed to result in any improvements in physician-assessed physical mobility although patient-reported stiffness, pain, spasticity, and spasms (but not shake/tremor) appeared to be improved with supplementation. This led to improvements in sleep quality, although symptoms of fatigue and depression were unaffected.

Full details on all 4 studies are available to Examine members — try free for 14 days.

Already a member? Log in now to access.